Biorem Inc. (BRM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 5,509 | 4,280 | 3,169 | 10,911 | 7,307 |
| Cost of Goods | 3,965 | 3,326 | 3,052 | 7,002 | 4,790 |
| Gross Profit | 1,544 | 954 | 117 | 3,909 | 2,518 |
| Operating Expenses | 794 | 839 | 923 | 2,519 | 1,342 |
| Operating Income | 750 | 114 | -806 | 1,390 | 1,176 |
| Interest Expense | 54 | 67 | 64 | 53 | 68 |
| Other Income | -12 | -179 | 117 | -76 | -72 |
| Pre-tax Income | 684 | -131 | -753 | 1,261 | 1,036 |
| Income Tax | 181 | -35 | -196 | 473 | 274 |
| Net Income Continuous | 503 | -96 | -557 | 788 | 761 |
| Net Income | $503 | $-96 | $-557 | $788 | $761 |
| EPS Basic Total Ops | 0.03 | -0.01 | -0.04 | 0.05 | 0.05 |
| EPS Basic Continuous Ops | 0.03 | -0.01 | -0.04 | 0.05 | 0.05 |
| EPS Diluted Total Ops | 0.03 | -0.01 | -0.04 | 0.05 | 0.04 |
| EPS Diluted Continuous Ops | 0.03 | -0.01 | -0.04 | 0.05 | 0.04 |
| EBITDA(a) | $787 | $-10 | $-607 | $1,433 | $1,163 |